A retrospective study of different treatments of limited-stage small-cell esophageal carcinoma and associated prognostic factor analysis.

@article{Ding2013ARS,
  title={A retrospective study of different treatments of limited-stage small-cell esophageal carcinoma and associated prognostic factor analysis.},
  author={Jing Ding and J Ji and Weiguo Zhu and K Zhou and Jihua Han and Y Zhang and C Yu and Tao Li and G Tao and Fu-zhi Ji and Xiaoyan Zhou and Peng Wei Pan},
  journal={Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus},
  year={2013},
  volume={26 7},
  pages={696-702}
}
Primary, small-cell esophageal carcinoma (SCEC) is a rare but highly malignant tumor. Due to lack of randomized, controlled, prospective studies, there are currently no unified treatment modalities for SCEC. This study retrospectively analyzed the outcomes of different treatments and prognostic factors that influence overall survival in patients with limited-stage SCEC. The study included 106 patients pathologically diagnosed with limited-stage SCEC at Huai'an First People's Hospital, Nanjing… CONTINUE READING

5 Figures & Tables

Connections & Topics

Mentioned Connections BETA
Fourteen patients received surgery alone , 42 received surgery and postoperative chemotherapy , 11 received radiotherapy alone , and 39 received concurrent chemoradiotherapy .
All Topics